期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

假病毒的最新应用研究进展 被引量：6

下载PDF
导出
作者 张玉松 王大燕 徐红 舒跃龙
机构地区 中国疾病预防控制中心/病毒病预防控制所国家流感中心/传染病预防控制国家重点实验室
出处 《医学研究杂志》 2008年第6期116-118,共3页 Journal of Medical Research
基金 国家高技术研究发展计划(863计划)资助项目(2006AA02Z410)
关键词 假病毒 细胞周期依赖性 病毒安全性 中和抗体效价 宿主细胞 埃博拉病毒 SARS H5N1
分类号 R373 [医药卫生—病原生物学] R730.264 [医药卫生—肿瘤]
  • 相关文献

参考文献12

  • 1John A G. Bfiggs,Thomas W,Stephen D F. Do lipid rafts mediate virus assembly and pseudotyping. J Gen Virol,2003,84 :757 -768
  • 2Giroglou T, Cinatl J J, Rabenau H, et al. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.J Virol,2004,78:9007- - 9015
  • 3David Avram Sanders. No false start for novel pseudotyped vectors. Current Opinion in Biotechnology ,2002 ,13 :437 - 442
  • 4Zhang B ,Jin S,Jin J,et al. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophagetropic equine lentivirus. Proc Natl Acad Sol USA ,2005,102:9918 - 9923
  • 5Li M ,Gao F, Mascola J R,et al. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine - elicited neutralizing antibodies. J Virol,2005, 79:10108 - 10125
  • 6Nigel J. Temperton, Paul K. Chan, et al. Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes. Emerging Infectious Diseases ,2005,11 ( 3 ) 411 - 416
  • 7Isabelle Nefkens, Jean - Michel Garcia et al. Hemagglutinin pseudotyped lentiviral particles: Characterization of a new method for avian H5N1 influenza sero - diagnosis. Journal of Clinical Virology,2007, 27 - 33
  • 8Nigel J. Temperton,J. Hoschler,et al. A sensitive retroviral pseudotype assay for influenza H5N1 - neutralizing antibodies. Influenza and Other Respiratory Viruses,2007,1 (3) : 105 - 112
  • 9Wang ZG, Li LJ, Luo Y, et al. Molecular biological analysis of genotypining and phylogeny of severe acute respiratory syndrome associated coronavir. Chinese Medical Journal(English) ,2004,117 ( 1 ) :42 - 48
  • 10Miletic H,Fischer YH,Giroglou T,et al. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma. Clin Cancer Res,2007,13 (22) :6761 - 6768

同被引文献98

  • 1李振勇,景建洲,刘明霞,邵大晓,冯艳铭,李智涛,宋国英,王秋旗,王云龙,屈凌波,赵玉芬.含SARS CoV RNA病毒样颗粒的构建和表达[J].第四军医大学学报,2004,25(20):1858-1861. 被引量：5
  • 2刘春国,阎丽辉,曹殿军.病毒样颗粒技术应用的研究进展[J].中国预防兽医学报,2005,27(2):157-160. 被引量：9
  • 3黄杰,王忠芳,杨昌梅,李金明.利用MS2噬菌体包膜蛋白与RNA的特异性相互作用构建临床检测用病毒样颗粒[J].中华检验医学杂志,2007,30(3):323-324. 被引量：1
  • 4Malek L, Sooknanan R, Compton J. Nucleic acid sequence-based amplification (NASBA) [J]. Methods Mol Biol,1994,28:253-260.
  • 5Romano J W, Williams K G, Shurtliff R N, et al. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics [J]. Immunol Invest, 1997,26(1-2): 15-28.
  • 6Collins M L, Irvine B,Tyner D, et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml [J]. Nucleic Acids Res,1997, 25 (15):2979- 2984.
  • 7Pastenack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women [J].J Clin Microbiol,1997,35 (3):676-678.
  • 8Pasloske B L, Walkrpeach C R,Obermoeller R D, et al. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards [J]. J Clin Microbiol,1998,36(12): 3590-3594.
  • 9Briqqs J A, Wilk T, Fuller S D. Do lipid rafts mediate virus assembly and pseudotypingμ [J]. J Gen Virol,2003,84 (4):757-768.
  • 10WalkerPeach C R, Winkler M, DuBois D B, et al. Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus [J]. Clin Chem,1999,45 (12): 2079-2085.

引证文献6

二级引证文献14

医学研究杂志
2008年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部